Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 May 24 424B3 Prospectus supplement
- 22 Apr 24 424B3 Prospectus supplement
- 18 Apr 24 424B3 Prospectus supplement
- 28 Mar 24 424B3 Prospectus supplement
- 28 Mar 24 EFFECT Notice of effectiveness
- 26 Mar 24 POS AM Prospectus update (post-effective amendment)
- 9 Jan 24 424B3 Prospectus supplement
- 26 Dec 23 EFFECT Notice of effectiveness
- 22 Dec 23 424B3 Prospectus supplement
- 20 Dec 23 S-1/A IPO registration (amended)
-
1 Dec 23 S-1/A IPO registration (amended)
- 6 Nov 23 S-3 Shelf registration
KRRO similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-3 (No. 333-275353) on Form S-1 of Korro Bio, Inc. of our report dated March 10, 2023, except for the effect of the reverse stock split discussed in Note 19b, as to which the date is December 1, 2023, relating to the consolidated financial statements of Frequency Therapeutics, Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
Boston, Massachusetts
December 1, 2023